SCHEMBL18855425

SCHEMBL18855425

CCOC(=O)c1cn2c(cnc3c2ccn3[S+]([O-])c2ccc(C)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.46
▸ KDM4E B2RXH2 6/20 0.43
▸ POLB P06746 1/20 0.43
▸ RAB9A P51151 5/20 0.40
▸ GLA P06280 3/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ GABRB2 P47870 2/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ AKT1 P31749 1/20 0.36
▸ AKT2 P31751 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1934058 0.80 GAA (0.47) GAAKDM4EPOLBRAB9AGLA
SCHEMBL18855535 0.73 DRD1 (0.31) —
SCHEMBL18855751 0.71 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL24797975 0.70 ELANE (0.47) GAAKDM4ERAB9AGLACYP1A2
SCHEMBL10730203 0.70 GAA (0.61) GAAKDM4EPOLBRAB9ACYP1A2
Bromide SCHEMBL11083368 0.69 GAA (0.60) GAAKDM4EPOLBRAB9ACYP1A2
SCHEMBL871014 0.67 KDM4E (0.69) GAAKDM4EPOLBRAB9AGLA
SCHEMBL11369182 0.66 GAA (0.52) GAAKDM4EPOLBRAB9ACYP1A2
SCHEMBL15176026 0.65 KDM4E (0.62) GAAKDM4EPOLBRAB9AGLA
SCHEMBL101291 0.64 GAA (1.00) GAAKDM4EPOLBRAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950692-A1 NOVEL TRICYCLIC COMPOUNDS AbbVie Inc. (US) 2022-02-09 — — EP disclosed
EP-2506716-B1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC (US) 2017-05-17 — — EP disclosed
Send feedback